EP0806900B1 - Medicated animal foodstuffs - Google Patents
Medicated animal foodstuffs Download PDFInfo
- Publication number
- EP0806900B1 EP0806900B1 EP96900355A EP96900355A EP0806900B1 EP 0806900 B1 EP0806900 B1 EP 0806900B1 EP 96900355 A EP96900355 A EP 96900355A EP 96900355 A EP96900355 A EP 96900355A EP 0806900 B1 EP0806900 B1 EP 0806900B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- gel
- pellets
- added
- gelling agent
- mixer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 17
- 239000008188 pellet Substances 0.000 claims abstract description 37
- 239000004615 ingredient Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000003814 drug Substances 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 16
- 238000011109 contamination Methods 0.000 claims abstract description 7
- 239000003349 gelling agent Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 241000283690 Bos taurus Species 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 241000282887 Suidae Species 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 239000007952 growth promoter Substances 0.000 claims description 3
- 239000011236 particulate material Substances 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 229920001059 synthetic polymer Polymers 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 230000002141 anti-parasite Effects 0.000 claims description 2
- 230000000842 anti-protozoal effect Effects 0.000 claims description 2
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 239000003096 antiparasitic agent Substances 0.000 claims description 2
- 238000010923 batch production Methods 0.000 claims description 2
- 239000008119 colloidal silica Substances 0.000 claims description 2
- 229960001438 immunostimulant agent Drugs 0.000 claims description 2
- 239000003022 immunostimulating agent Substances 0.000 claims description 2
- 230000003308 immunostimulating effect Effects 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 230000009974 thixotropic effect Effects 0.000 claims description 2
- 229960005486 vaccine Drugs 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 239000003904 antiprotozoal agent Substances 0.000 claims 1
- 239000004927 clay Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 description 28
- 239000000047 product Substances 0.000 description 15
- 238000000576 coating method Methods 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 8
- 241000251468 Actinopterygii Species 0.000 description 5
- -1 but not exclusively Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000004099 Chlortetracycline Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000007900 aqueous suspension Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 3
- 235000019365 chlortetracycline Nutrition 0.000 description 3
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 3
- 229960004475 chlortetracycline Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000005112 continuous flow technique Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 2
- 229960001082 trimethoprim Drugs 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- MOOFYEJFXBSZGE-QJUDHZBZSA-N 1,2-bis[(z)-(4-chlorophenyl)methylideneamino]guanidine Chemical compound C=1C=C(Cl)C=CC=1\C=N/N=C(/N)N\N=C/C1=CC=C(Cl)C=C1 MOOFYEJFXBSZGE-QJUDHZBZSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- UMZCLZPXPCNKML-UHFFFAOYSA-N 2h-imidazo[4,5-d][1,3]thiazole Chemical class C1=NC2=NCSC2=N1 UMZCLZPXPCNKML-UHFFFAOYSA-N 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000004190 Avilamycin Substances 0.000 description 1
- 229930192734 Avilamycin Natural products 0.000 description 1
- 239000004184 Avoparcin Substances 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- ZDPIZLCVJAAHHR-UHFFFAOYSA-N Clopidol Chemical compound CC1=NC(C)=C(Cl)C(O)=C1Cl ZDPIZLCVJAAHHR-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229930182504 Lasalocid Natural products 0.000 description 1
- 229930191564 Monensin Natural products 0.000 description 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 1
- VHKXXVVRRDYCIK-CWCPJSEDSA-N Narasin Chemical compound C[C@H]1C[C@H](C)[C@H]([C@@H](CC)C(O)=O)O[C@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-CWCPJSEDSA-N 0.000 description 1
- VHKXXVVRRDYCIK-UHFFFAOYSA-N Narasin Natural products CC1CC(C)C(C(CC)C(O)=O)OC1C(C)C(O)C(C)C(=O)C(CC)C1C(C)CC(C)C2(C=CC(O)C3(OC(C)(CC3)C3OC(C)C(O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004189 Salinomycin Substances 0.000 description 1
- KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004188 Virginiamycin Substances 0.000 description 1
- 108010080702 Virginiamycin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- XIRGHRXBGGPPKY-OTPQUNEMSA-N [(2r,3s,4r,6s)-6-[(2'r,3's,3ar,4r,4'r,6s,7ar)-6-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4s,5s,6s)-6-[(2r,3as,3'ar,6'r,7r,7's,7ar,7'ar)-7'-acetyl-7'-hydroxy-6'-methyl-7-(2-methylpropanoyloxy)spiro[4,6,7,7a-tetrahydro-3ah-[1,3]dioxolo[4,5-c]pyran-2,4'-6,7a-dihydro-3ah- Chemical compound O([C@H]1[C@H](O)C[C@@H](O[C@@H]1C)O[C@H]1[C@H](O)CC2(O[C@]3(C)C[C@@H](O[C@H](C)[C@H]3O2)O[C@H]2[C@@H](OC)[C@@H](C)O[C@H]([C@@H]2O)O[C@H]2[C@H](O)[C@H](OC)[C@H](OC3[C@@H]([C@@H]4O[C@]5(O[C@H]4CO3)[C@@H]3OCO[C@H]3[C@@](O)([C@@H](C)O5)C(C)=O)OC(=O)C(C)C)O[C@@H]2COC)O[C@@H]1C)C(=O)C1=C(C)C(Cl)=C(O)C(Cl)=C1OC XIRGHRXBGGPPKY-OTPQUNEMSA-N 0.000 description 1
- GANNOFFDYMSBSZ-UHFFFAOYSA-N [AlH3].[Mg] Chemical compound [AlH3].[Mg] GANNOFFDYMSBSZ-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229960003683 amprolium Drugs 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 229940036589 antiprotozoals Drugs 0.000 description 1
- 229940058299 avermectines Drugs 0.000 description 1
- 235000019379 avilamycin Nutrition 0.000 description 1
- 229960005185 avilamycin Drugs 0.000 description 1
- 235000019377 avoparcin Nutrition 0.000 description 1
- JWFVWARSGMYXRN-HTQQBIQNSA-N avoparcin Chemical compound O([C@H]1[C@H](C(N[C@H](C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(N[C@H](C4=CC(O)=CC(O)=C4C=4C(O)=CC=C3C=4)C(O)=O)=O)CC3=C(O[C@@H]4O[C@@H](C)[C@H](O)[C@H](N)C4)C=C(C(=C3)Cl)OC=3C=C2C=C(C=3O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2O[C@@H](C)[C@H](O)[C@H](N)C2)OC2=CC=C1C=C2)C=1C=CC(O)=CC=1)=O)NC(=O)[C@@H](NC)C=1C=CC(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)=CC=1)[C@@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@H]1O JWFVWARSGMYXRN-HTQQBIQNSA-N 0.000 description 1
- 229950001335 avoparcin Drugs 0.000 description 1
- 108010053278 avoparcin Proteins 0.000 description 1
- PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 description 1
- 229950007118 bambermycin Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 229960000731 clopidol Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- IBXPYPUJPLLOIN-UHFFFAOYSA-N dimetridazole Chemical compound CC1=NC=C(N(=O)=O)N1C IBXPYPUJPLLOIN-UHFFFAOYSA-N 0.000 description 1
- 229960000946 dimetridazole Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000019374 flavomycin Nutrition 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 229960003704 framycetin Drugs 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229950010152 halofuginone Drugs 0.000 description 1
- LVASCWIMLIKXLA-LSDHHAIUSA-N halofuginone Chemical compound O[C@@H]1CCCN[C@H]1CC(=O)CN1C(=O)C2=CC(Cl)=C(Br)C=C2N=C1 LVASCWIMLIKXLA-LSDHHAIUSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- PJBQYZZKGNOKNJ-UHFFFAOYSA-M hydron;5-[(2-methylpyridin-1-ium-1-yl)methyl]-2-propylpyrimidin-4-amine;dichloride Chemical compound Cl.[Cl-].NC1=NC(CCC)=NC=C1C[N+]1=CC=CC=C1C PJBQYZZKGNOKNJ-UHFFFAOYSA-M 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000320 lasalocid Drugs 0.000 description 1
- BBMULGJBVDDDNI-OWKLGTHSSA-N lasalocid Chemical compound C([C@@H]1[C@@]2(CC)O[C@@H]([C@H](C2)C)[C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC=2C(=C(O)C(C)=CC=2)C(O)=O)C[C@](O)(CC)[C@H](C)O1 BBMULGJBVDDDNI-OWKLGTHSSA-N 0.000 description 1
- 229940041028 lincosamides Drugs 0.000 description 1
- 238000013187 longer-term treatment Methods 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 229950006915 maduramicin Drugs 0.000 description 1
- RWVUEZAROXKXRT-VQLSFVLHSA-N maduramicin Chemical compound O1[C@@H](C)[C@H](OC)[C@@H](OC)C[C@H]1O[C@@H]1[C@H]([C@@]2(C)O[C@H](CC2)[C@@]2(C)O[C@]3(O[C@@H]([C@H](C)[C@@H](O)C3)[C@@H](C)[C@H]3[C@@H]([C@@H](OC)[C@H](C)[C@@](O)(CC(O)=O)O3)OC)CC2)O[C@@H]([C@@H]2[C@H](C[C@@H](C)[C@@](C)(O)O2)C)C1 RWVUEZAROXKXRT-VQLSFVLHSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 229960005358 monensin Drugs 0.000 description 1
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 1
- 229960001851 narasin Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960004591 robenidine Drugs 0.000 description 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical class OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 description 1
- 235000019378 salinomycin Nutrition 0.000 description 1
- 229960001548 salinomycin Drugs 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960004885 tiamulin Drugs 0.000 description 1
- UURAUHCOJAIIRQ-QGLSALSOSA-N tiamulin Chemical compound CCN(CC)CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 UURAUHCOJAIIRQ-QGLSALSOSA-N 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 235000019373 virginiamycin Nutrition 0.000 description 1
- 229960003842 virginiamycin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UCRLQOPRDMGYOA-DFTDUNEMSA-L zinc;(4r)-4-[[(2s)-2-[[(4r)-2-[(1s,2s)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2s,3s)-1-[[(3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carbox Chemical compound [Zn+2].C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC([O-])=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@H](CC([O-])=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 UCRLQOPRDMGYOA-DFTDUNEMSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/807—Poultry or ruminant feed
Definitions
- This invention relates to methods for incorporating feed ingredients (particularly, but not exclusively, medicaments) with animal foodstuffs, and to substances useful in such methods.
- Treatment of intensively farmed animals with medication is often carried out by "mass medication", that is to say that animals are not treated individually, but as a group. The most efficient way of doing this is by adding the treatment to the animals' feed or drink. Water medication is very labour intensive and may require veterinary supervision, and longer term treatments are much more easily carried out by supplying the group of animals with medicated feed.
- Manufactured foodstuffs for animals such as cattle, pigs, and fowl are usually provided in the form of pellets or similar particulate material.
- Pellets are typically manufactured by combining a cereal base with ingredients such as oil and protein, steam conditioning the mixture (for example at 70°C for 5 minutes), extruding through a circular die (typically between 2mm and 15mm in diameter), cutting into appropriately sized lengths (eg. 5-20mm), and drying.
- the finished pellets are generally cylindrically shaped, having a relatively smooth surface, and a density typically of about 1.2g.cm -3 .
- additives such as drugs are incorporated into the feed mixture before the extrusion step.
- many different drugs are required to be added to feed pellets from time to time, and because the demand for any particular medicated product is generally relatively low compared to the demand for non-medicated feed, it is not usually viable to provide dedicated plant for manufacturing specific products. Instead, batches of medicated feed are manufactured according to need using machinery otherwise used to produce non-medicated feed.
- a major problem with this manufacturing regime is that the plant needs to be completely cleaned down after the production of each batch of medicated feed, in order to reduce the risk of contaminating subsequent feed batches. This obviously reduces efficiency and increases operating costs.
- EP-A-0,231,817 discloses the coating of feed pellets with nutritional supplements such as vitamins, and it is stated (for example at Column 3, lines 35 to 36) that the preferred vehicles for the vitamins are oils.
- the vitamin-containing oil is applied to the pellets in a continuous flow process in which the pellets are fed into a rotating drum whose axis of rotation is inclined to the horizontal.
- the oil is sprayed onto the pellet by means of a lance disposed within the drum, and the pellets become coated with the oil both by means of direct spraying and as a result of tumbling within the drum.
- the pellets move towards the lower end of the drum, and eventually exit through an outlet port.
- JP 60-12939 relates to the addition of pharmaceuticals to fish food in the form of whole fish, sliced fish or wet pellets.
- a coating containing the pharmaceutical is applied to the fish food immediately before feeding to the fish.
- the coating is applied in the form of a dried powder which absorbs moisture from the surface of the foodstuff and adheres to it. It is therefore essential that the surface of the foodstuff be wet, and the method is accordingly unsuitable for use with dry pellets.
- the powder is simply sprinkled onto the moist foodstuff and immediately adheres thereto, accuracy of dosage and homogeneity of the coated product are likely to be poor.
- US 3,639,637 also relates to the addition of an active substance to an animal foodstuff immediately prior to feeding to the animal.
- This patent is concerned specifically with the administration of the growth promoter diethylstibestrol to cattle and the problems associated with the formulation of a stable aqueous suspension of this particular compound.
- the patent proposes a dry powder formulation, the essential ingredients of which are freely divided diethylstilbestrol and microcrystalline cellulose. The powder is then made up into an aqueous suspension by addition of tap water and added to the animal foodstuff prior to feeding to the animals.
- the identity of the foodstuff and the precise method of application are not specified (though spraying is mentioned as the conventional method) and there is no suggestion that a particularly good accuracy or homogeneity are achieved.
- the present invention therefore provides, in one aspect, a batch process method of incorporating an added ingredient with an animal foodstuff in the form of pellets or similar particular foodstuff material, suitable for feeding to animals such as cattle, pigs and fowl, the method comprising the steps of: placing a quantity of said pellets or similar particulate material into a mixer; adding to said mixer a cohesive gel containing said added ingredient; and mixing said gel with said pellets or other particulate foodstuff material so that the latter become substantially homogeneously coated with said gel, and the walls of the mixer are left substantially free of added ingredient contamination after mixing.
- the method has the advantage that the amount and distribution of added ingredient may be controlled sufficiently accurately to render the method suitable for the incorporation of medicaments as well as non-medicated additives.
- the pellets may be fed to animals directly after coating, but more commonly the gel is dried or absorbed into the pellet, thus entrapping the medication in the pellet and giving protection against attrition and the formation of active agent dust.
- the term "gel” is to be understood as referring to any viscous cohesive suspension, and the term “gelling agent” to any thickening agent capable of producing such a suspension.
- the gel is preferably a highly viscous solution or suspension (for example an aqueous suspension), having low flow and good adhesive properties.
- Thixotropic gels may be used.
- the viscosity should be controlled within the range 5,000 to 20,000 cP (Brookfield RV, spindle 6, 25 rpm, 20°C), more preferably in the range 5,000 to 15,000 cP, and ideally in the range 7,500 to 12,500 cP. This viscosity range allows added ingredients having particles of a wide variety of sizes and densities to be homogeneously suspended, and also gives the gel the necessary cohesive properties for good feed pellet distribution and low mixer contamination.
- suitable gelling agents which may be used for this purpose are modified cellulose polymers, synthetic polymers, natural polysaccharides, clays, proteins and colloidal silica, but other gelling agents may also be used.
- the gel can be supplied to users ready mixed with the added ingredient(s), or as a raw gel, for such ingredient(s) to be added.
- the gelling agent may be provided in powder form and made up to the finished gel when required, with the added ingredient(s) being either mixed in at the outset, or being added after the gel is made up.
- the mixing can be accomplished by adding water, oil, or another appropriate liquid, and mixing vigorously (for example in a high speed planetary mixer) to shear the mixture and allow complete hydration of the gelling agent.
- the amount of liquid will depend on the gelling agent used, and on the ratio of gelling agent to other ingredients in the powder; typically the final gel will contain 1 to 50% w/w (preferably 1 to 10% w/w) of the gelling agent.
- modified cellulose polymers which may be used as the gelling agent are: sodium carboxymethylcellulose, methylcellulose, hydroxypropylmethylcellulose, hydroxymethylcellulose, hydroxypropylcellulose, ethylcellulose, hydroxyethylcellulose, and microcrystalline cellulose.
- Suitable synthetic polymers are: polyacrilic acid polymers (Carbomers) , polyvinylpyrrolidones (PVPs), crospovidones, polyvinyl alcohols, and colloidal anhydrous silicas.
- Examples of natural polysaccharides which may be used include: xanthan gum, acacia gum, agar, carrageenan and tragacanth.
- Suitable clays are bentonite and aluminium magnesium silicates, and an example of a suitable protein is gelatin.
- the invention may be used to incorporate many different types of added ingredient or combinations of added ingredients.
- medicaments which may be used are: antimicrobials (such as tetracyclines, penicillins, sulphonamides, cephalosporins, cephamycins, aminoglycosides, aminocyclitols, trimethoprim, dimetridazole, erythromycin, framycetin, furazolidone, lincosamides, tiamulin, macrolides, and streptomycin); antiprotozoals (such as clopidol, monensin, salinomycin, narasin, halofuginone, lasalocid, amprolium, maduramicin, and robenidine) ; and antiparasitics (such as benzimidazoles, imidazothiazoles, avermectines, milbermycins, salicylicanilides and piperazine).
- antimicrobials such as tetracyclines, pen
- Examples of other added ingredients are growth promoters (such as tylosin, virginiamycin, zinc bacitracin, avoparcin bambermycin, avilamycin); vaccines (for example to prevent E. coli infections) ; immunostimulants; vitamins (such as vitamin A, B group vitamins, vitamins C, D, E and K3) ; minerals (for example salts containing micronutrients, such as iron, zinc, copper, selenium, iodine, manganese, calcium and phosphorus); and enzymes.
- concentration of total added ingredients in the gel will typically range from 0.5 to 10% w/w of the final gel.
- a preservative typically in a concentration of 0.05-5% w/w of the final gel
- suitable preservatives are: parabens, benzoic acid and salts, propionic acid and salts, sorbic acid and salts, bronopol and formaldehyde.
- the final formulations of the products may also include other adjuvants such as dispersing or wetting agents (such as surfactants e.g. Tweens, Brijs, sodium lauryl sulphate), buffering agents (such as citric acid and citrates, phosphoric acid and phosphates) and diluents (such as lactose, calcium carbonate, silica and starch).
- dispersing or wetting agents such as surfactants e.g. Tweens, Brijs, sodium lauryl sulphate
- buffering agents such as citric acid and citrates, phosphoric acid and phosphates
- diluents such as lactose, calcium carbonate, silica and starch.
- the feed pellets and gel are preferably mixed relatively gently, to prevent the feed from disintegrating. Any low shear mixer with a blade which has a fine tolerance with the side of the mixing vessel is adequate, such as a planetary mixer or ribbon blender.
- the gel is gently added to (e.g. folded into) the feed pellets and slowly and uniformly coats them.
- the amount of gel added per tonne of feed appears to be critical and should be in the range 2-40kg/tonne. Less than 2kg/tonne gives poor product homogeneity, and over 40kg/tonne gives rise to damp (i.e. overly wetted) feed and possible mould growth in the finished feed pellets; more typically the amount used is in the range 5-20kg/tonne, and in many cases the amount is more than 10kg/tonne.
- All ingredients are thoroughly blended dry in a planetary mixer for 12 minutes, and the product transferred into polythene-lined sachets and heat-sealed.
- the product is used by adding sufficient water to a mixing vessel (eg. planetary mixer bowl) so that the suspending agent forms a 2.5% w/v solution. (For example, 1kg of product is blended with 5 litres of water.)
- the suspension is formed by mixing vigorously for 10 minutes.
- the product is suspended and the gel is sufficiently hydrated it is ready to coat the feed pellets.
- the pellets are weighed into a suitable mixer (eg ribbon blender) and the required amount of gel added to give the medication level required (eg for 400 mg/kg, add 20 litres/tonne). The mixture is blended for 5 minutes and dispensed into paper sacks.
- a suitable mixer eg ribbon blender
- the resultant coated feed when analysed for chlortetracycline content, gave a mean value of 412.6 mg/kg, with a coefficient of variation over 10 assays of 4.6%.
- the amount of contamination of the mixer as a percentage of the total chlortetracycline added was 0.023%.
- the product is prepared by dry blending as in Example 1.
- the suspension is formed by mixing 2kg of product with 20 litres of water as above. To obtain 300mg/kg of combined actives in the feed, 20 litres of gel is added per tonne of feed, and blended for 5 minutes.
- the coated pellets produced by these methods are found to have even distribution of medicament and good durability upon handling.
- the mixing vessel becomes coated with gel only to a minimal extent.
- the product is prepared by mixing the silica thoroughly with the oil to form a viscous gel base. Then the penicillin is blended into the mixture by using a high shear blender over 20 minutes. The product is packed into polypropylene pails and allowed to reach maximum viscosity. After 24 hours standing the viscosity is 18000cP (Brookfield RV, spindle 6, 25rpm, 20°C).
- the amount of contamination of the mixer was quantified as 0.007% of the total drug added.
Landscapes
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Fodder In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9500863.7A GB9500863D0 (en) | 1995-01-17 | 1995-01-17 | Medicated animal foodstuffs |
GB9500863 | 1995-01-17 | ||
PCT/GB1996/000073 WO1996022028A1 (en) | 1995-01-17 | 1996-01-16 | Medicated animal foodstuffs |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0806900A1 EP0806900A1 (en) | 1997-11-19 |
EP0806900B1 true EP0806900B1 (en) | 2001-04-04 |
Family
ID=10768133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96900355A Expired - Lifetime EP0806900B1 (en) | 1995-01-17 | 1996-01-16 | Medicated animal foodstuffs |
Country Status (16)
Country | Link |
---|---|
US (2) | US5948431A (es) |
EP (1) | EP0806900B1 (es) |
AT (1) | ATE200184T1 (es) |
AU (1) | AU4395396A (es) |
CA (1) | CA2210636C (es) |
DE (1) | DE69612373T2 (es) |
DK (1) | DK0806900T3 (es) |
ES (1) | ES2157418T3 (es) |
GB (1) | GB9500863D0 (es) |
GR (1) | GR3035927T3 (es) |
IL (1) | IL116779A (es) |
MY (1) | MY115785A (es) |
PT (1) | PT806900E (es) |
TW (1) | TW443917B (es) |
WO (1) | WO1996022028A1 (es) |
ZA (1) | ZA96265B (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10105305A1 (de) * | 2001-02-02 | 2002-08-14 | Nutrinova Gmbh | Sorbinsäurepräparat als Futtermittelzusatz in der Nutztieraufzucht |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9500863D0 (en) * | 1995-01-17 | 1995-03-08 | Grampian Pharm Ltd | Medicated animal foodstuffs |
US5725873A (en) * | 1996-07-22 | 1998-03-10 | Wisconsin Alumni Research Foundation | Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
CA2327692C (en) | 1999-02-10 | 2009-06-02 | Dsm N.V. | Granulates containing feed-enzymes |
DE19929257A1 (de) | 1999-06-25 | 2000-12-28 | Basf Ag | Polymerbeschichtete, granulierte enzymhaltige Futtermittelzusätze und Verfahren zu deren Herstellung |
GB9928343D0 (en) * | 1999-11-30 | 2000-01-26 | Vericore Ltd | Addition of tetracyclines to animal foodstuffs |
US6953593B2 (en) * | 2000-02-01 | 2005-10-11 | Lipoprotein Technologies, Inc. | Sustained-release microencapsulated delivery system |
EP1167148B1 (en) * | 2000-07-01 | 2008-02-06 | Robert Bosch GmbH | A method and apparatus for calculating actuation control of an FDR/ESP hydro-subassembly for reduction of hydraulic noises |
US20040009160A1 (en) * | 2001-06-22 | 2004-01-15 | Villamar Daniel F | Bioactive food complex, method for making bioactive food complex product and method for controlling disease |
US6753004B2 (en) * | 2001-09-04 | 2004-06-22 | Auburn University | Biodegradable fishing lure and material |
EP1297751A1 (de) | 2001-10-01 | 2003-04-02 | Bogar AG | Oral zu verabreichende Zubereitung |
US6866862B2 (en) * | 2001-10-05 | 2005-03-15 | Rubicon Scientific | Animal feeds including heartworm-prevention drugs |
US7052712B2 (en) * | 2001-10-05 | 2006-05-30 | Rubicon Scientific Llc | Animal feeds including actives and methods of preparing same |
US6716448B2 (en) | 2001-10-05 | 2004-04-06 | Rubicon Scientific Llc | Domesticated household pet food including maintenance amounts of ivermectin |
CO5390081A1 (es) * | 2001-11-28 | 2004-04-30 | Novartis Ag | Compuestos organicos |
DE60315412T3 (de) | 2002-01-15 | 2012-09-20 | Basf Se | Granulate enthaltend Futtermittelenzyme |
US20040091579A1 (en) * | 2002-11-13 | 2004-05-13 | Rubicon Scientific Llc; | Extruded foodstuffs having maintenance level actives |
DE10253193A1 (de) * | 2002-11-15 | 2004-06-03 | Degussa Ag | Mit Wachs, Öl oder Fetten beschichtete Kieselsäure, Kieselgele oder Silikate |
US20040228948A1 (en) * | 2003-05-16 | 2004-11-18 | Kennelly John J. | Increasing the concentration of conjugated linoleic acid isomers in the milk fat and/or tissue fat of ruminants |
ITMI20032225A1 (it) * | 2003-11-17 | 2005-05-18 | Dox Al Italia Spa | Processo per la preparazione di mangimi comprendenti additivi |
FR2889910B1 (fr) * | 2005-08-25 | 2012-02-10 | Virbac Sa | Produit pour la preparation d'aliments supplementes pour animaux |
ES2292315B1 (es) * | 2005-09-29 | 2009-02-16 | Laboratorios Maymo, S.A. | Procedimiento para la fabricacion de piensos medicados y aparato para la realizacion del mismo. |
DE102007033082B4 (de) * | 2007-07-13 | 2009-04-02 | Hans Plommer | Vorrichtung und Verfahren zum Herstellen eines Futtermittels aus Grünfutter |
ES2358705B1 (es) | 2009-11-03 | 2012-03-22 | Mangra, S.A. | Procedimiento y aparato para adicionar piensos. |
JP5431597B2 (ja) * | 2010-01-22 | 2014-03-05 | ザ・アイムス・カンパニー | コーティングされたキブルの形態でペットフードを製造する方法 |
CA2845576C (en) | 2011-08-24 | 2020-09-15 | Dupont Nutrition Biosciences Aps | Enzyme producing bacillus strains |
DE202011108001U1 (de) | 2011-11-17 | 2011-12-28 | Anja Glisovic | Materialien zur Herstellung von Tierspielzeugen und Zusatzfuttermitteln |
MX347401B (es) * | 2012-11-14 | 2017-04-18 | Univ Mexico Nac Autonoma | Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos. |
FR3002735B1 (fr) * | 2013-03-04 | 2015-07-03 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
FR3002736B1 (fr) | 2013-03-04 | 2015-06-26 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
CA2937666A1 (en) * | 2014-01-31 | 2015-08-06 | Morishita Jintan Co., Ltd. | Orally administered agent for ruminants and ruminant feed containing same |
MX2017013715A (es) | 2015-04-28 | 2018-03-02 | Mars Inc | Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado. |
GB2543530A (en) * | 2015-10-20 | 2017-04-26 | Huvepharma Eood | Apparatus & Method for manufacturing liquid enzyme, and a system & method for coating pellets with the liquid enzyme |
CN116509805B (zh) * | 2023-06-14 | 2023-11-21 | 武汉诺见生物技术有限公司 | 一种酒石酸泰万菌素制剂的制备方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE284585C (es) | ||||
US2485669A (en) | 1945-04-28 | 1949-10-25 | White Lab Inc | Poultry feeding composition |
GB850489A (en) | 1958-03-27 | 1960-10-05 | J & J Colman Ltd | Improvements in or relating to food particularly for cage birds |
US3639637A (en) * | 1968-04-23 | 1972-02-01 | Richardson Merrell Inc | Water dispersible diethylstilbestrol compositions |
US4089979A (en) * | 1972-06-30 | 1978-05-16 | Imperial Chemical Industries Limited | Formulation of feed additives, mineral supplements and liquid feeds for animals and preservatives for silage, hay and grain |
DE2437780A1 (de) | 1974-08-06 | 1976-02-19 | Karl Dr Med Theurer | Naehr-, nahrungs- und genussmittel einschliesslich von milchprodukten und margarine mit prophylaktisch-therapeutischer, resistenzfoerdernder, anaboler wirkung sowie eine besondere anwendungsform fuer tierfutter |
JPS5963147A (ja) * | 1982-10-05 | 1984-04-10 | Marine Project:Kk | 養魚餌料の改質法 |
JPS6012939A (ja) * | 1983-07-01 | 1985-01-23 | Kanegafuchi Chem Ind Co Ltd | 展着性薬剤組成物およびそれを利用した薬剤投与方法 |
GB8326633D0 (en) | 1983-08-04 | 1983-11-09 | Unilever Plc | Compositions |
US4935250A (en) | 1984-05-01 | 1990-06-19 | Inverness Management Corporation | Coated fish feed pellets |
CH666386A5 (de) * | 1986-02-03 | 1988-07-29 | Buehler Ag Geb | Verfahren zum herstellen von formlingen eines nahrungsmittels sowie anlage und bespruehtrommel hierfuer. |
SE454230C (sv) * | 1986-04-07 | 1990-03-05 | Medipharm Ab | Foerfarande foer tillfoersel av laaga halter biologiskt aktivt material till basmaterial, saasom processat livsmedel eller djurfoder |
GB8707740D0 (en) * | 1987-04-01 | 1987-05-07 | Strathclyde Minerals Ltd | Composition |
US5000943A (en) * | 1989-05-30 | 1991-03-19 | Nabisco Brands, Inc. | Canine biscuits containing an inorganic pyrophosphate |
US5011679A (en) * | 1989-05-30 | 1991-04-30 | Nabisco Brands, Inc. | Raw hide having a coating containing an inorganic pyrophosphate |
CH680896A5 (en) * | 1990-03-21 | 1992-12-15 | Ufag | Fodder, food or additive for vertebrates esp. herbivores - comprises core contg. solid fat or fatty acid surrounded by casing contg. water-soluble carbohydrate |
US5120565A (en) * | 1990-10-05 | 1992-06-09 | Purina Mills, Inc. | Extruded, high-fat animal feed nugget |
DE4325658C2 (de) * | 1993-07-30 | 1995-06-08 | Chevita Tierarzneimittel Ges M | Verfahren zur Herstellung von Futtermitteln, die pharmakologisch wirksame Substanzen enthalten |
IT1265290B1 (it) * | 1993-12-17 | 1996-10-31 | Dox Al Italia Spa | Miscele ad elevato contenuto di sostanze attive idonee ad essere distribuite in modo omogeneo nei mangimi per animali. |
ATE228773T1 (de) | 1994-10-20 | 2002-12-15 | Chevita Tierarzneimittel Ges M | Verfahren zur herstellung von futtermitteln, die pharmakologisch wirksame substanzen enthalten |
GB9500863D0 (en) * | 1995-01-17 | 1995-03-08 | Grampian Pharm Ltd | Medicated animal foodstuffs |
US5650184A (en) * | 1995-02-21 | 1997-07-22 | Moorman Manufacturing Company | Coated feed agglomerates and methods of making the same |
US5698246A (en) * | 1996-01-29 | 1997-12-16 | Cargill, Incorporated | Foodstuff for and method of feeding crustaceans and fish |
-
1995
- 1995-01-17 GB GBGB9500863.7A patent/GB9500863D0/en active Pending
-
1996
- 1996-01-12 ZA ZA96265A patent/ZA96265B/xx unknown
- 1996-01-15 MY MYPI96000138A patent/MY115785A/en unknown
- 1996-01-16 DE DE69612373T patent/DE69612373T2/de not_active Expired - Fee Related
- 1996-01-16 CA CA002210636A patent/CA2210636C/en not_active Expired - Fee Related
- 1996-01-16 PT PT96900355T patent/PT806900E/pt unknown
- 1996-01-16 ES ES96900355T patent/ES2157418T3/es not_active Expired - Lifetime
- 1996-01-16 EP EP96900355A patent/EP0806900B1/en not_active Expired - Lifetime
- 1996-01-16 US US08/860,979 patent/US5948431A/en not_active Expired - Fee Related
- 1996-01-16 WO PCT/GB1996/000073 patent/WO1996022028A1/en active IP Right Grant
- 1996-01-16 DK DK96900355T patent/DK0806900T3/da active
- 1996-01-16 IL IL11677996A patent/IL116779A/xx not_active IP Right Cessation
- 1996-01-16 AU AU43953/96A patent/AU4395396A/en not_active Abandoned
- 1996-01-16 AT AT96900355T patent/ATE200184T1/de not_active IP Right Cessation
- 1996-02-01 TW TW085101366A patent/TW443917B/zh not_active IP Right Cessation
-
1999
- 1999-05-26 US US09/318,973 patent/US6387393B1/en not_active Expired - Fee Related
-
2001
- 2001-05-25 GR GR20010400780T patent/GR3035927T3/el not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10105305A1 (de) * | 2001-02-02 | 2002-08-14 | Nutrinova Gmbh | Sorbinsäurepräparat als Futtermittelzusatz in der Nutztieraufzucht |
Also Published As
Publication number | Publication date |
---|---|
GB9500863D0 (en) | 1995-03-08 |
ATE200184T1 (de) | 2001-04-15 |
DK0806900T3 (da) | 2001-07-23 |
MY115785A (en) | 2003-09-30 |
DE69612373D1 (de) | 2001-05-10 |
TW443917B (en) | 2001-07-01 |
IL116779A (en) | 1999-07-14 |
IL116779A0 (en) | 1996-05-14 |
ZA96265B (en) | 1996-08-01 |
PT806900E (pt) | 2001-09-28 |
EP0806900A1 (en) | 1997-11-19 |
GR3035927T3 (en) | 2001-08-31 |
US5948431A (en) | 1999-09-07 |
DE69612373T2 (de) | 2001-09-27 |
ES2157418T3 (es) | 2001-08-16 |
WO1996022028A1 (en) | 1996-07-25 |
CA2210636C (en) | 2005-07-26 |
CA2210636A1 (en) | 1996-07-25 |
US6387393B1 (en) | 2002-05-14 |
AU4395396A (en) | 1996-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0806900B1 (en) | Medicated animal foodstuffs | |
US10039717B2 (en) | Method of preparing biologically active formulations | |
US5244669A (en) | Feed additives for ruminants | |
JPH06511255A (ja) | 微結晶性セルローススフェロニゼーション組成物 | |
EP2046140B1 (en) | Compositions of microparticles and granules for oral controlled release of substances for veterinary use | |
EP0958812B1 (en) | Spherical particle groups, process for preparing the same and spherical particulate pharmaceuticals using the same | |
EP0363733B1 (en) | Method for preparing mixtures for human and animal feed use containing uniformly distributed active substances | |
EP1337158B1 (en) | Process for the preparation of granules of methionine | |
CZ2006269A3 (cs) | Pelety obsahující hydrochlorid venlafaxinu | |
EP0658313B1 (en) | Method for preparing high-drug-content mixtures suitable for uniform distribution in feeds | |
US4665100A (en) | Process for formulating a synthetic drug for use in animal feed, and resulting formulation | |
CA1200203A (en) | Process for formulating a medicated animal feed premix | |
US8906407B2 (en) | Protected active compound formulations of amino acids and process for their preparation | |
US20080044516A1 (en) | Granules of Hydrophilic Active Principle | |
US8652547B2 (en) | Process for preparing granules of hydrophilic active principle by extrusion | |
JP3430618B2 (ja) | ペレット化可能な反芻動物用ルーメンバイパス製剤 | |
EP1360904B1 (en) | Protected compound formulations of amino acids and process for their preparation | |
US20240226045A9 (en) | Rumen-protected compositions and methods of making the same | |
JPH05260905A (ja) | 家畜用飼料添加物およびそれを用いた家畜用飼料 | |
US20240306669A1 (en) | Raw-fiber crusted pellets, feedstuff containing them, and corresponding methods and uses | |
CN118078761A (zh) | 一种拉沙洛西钠微丸及其制备方法 | |
CN116437814A (zh) | 用于反刍动物口服的生物活性成分的包衣组合物 | |
EP1919299A1 (fr) | Produit pour la preparation d'aliments supplementes pour animaux | |
WO2005034918A1 (en) | Pellets containing a pharmaceutical ingredient | |
JPH08140586A (ja) | 薬学的有効物質を含む飼料の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970804 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19981125 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: VERICORE LIMITED |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
REF | Corresponds to: |
Ref document number: 200184 Country of ref document: AT Date of ref document: 20010415 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 69612373 Country of ref document: DE Date of ref document: 20010510 |
|
ITF | It: translation for a ep patent filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAE |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2157418 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20010619 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050116 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: MC Payment date: 20071224 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20080218 Year of fee payment: 13 Ref country code: DK Payment date: 20080115 Year of fee payment: 13 Ref country code: CH Payment date: 20080116 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20080110 Year of fee payment: 13 Ref country code: SE Payment date: 20080104 Year of fee payment: 13 Ref country code: PT Payment date: 20071221 Year of fee payment: 13 Ref country code: NL Payment date: 20080103 Year of fee payment: 13 Ref country code: LU Payment date: 20080114 Year of fee payment: 13 Ref country code: IE Payment date: 20080111 Year of fee payment: 13 Ref country code: GR Payment date: 20071030 Year of fee payment: 13 Ref country code: GB Payment date: 20080116 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: VERICORE LIMITED Free format text: VERICORE LIMITED#MARATHON PLACE, MOSS SIDE INDUSTRIAL ESTATE#LEYLAND, LANCASHIRE PR5 3QN (GB) -TRANSFER TO- VERICORE LIMITED#MARATHON PLACE, MOSS SIDE INDUSTRIAL ESTATE#LEYLAND, LANCASHIRE PR5 3QN (GB) |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20080114 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20080108 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20080407 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20090716 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090131 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
EUG | Se: european patent has lapsed | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20090116 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20090801 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090716 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090131 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090801 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090131 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090116 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20091030 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090801 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090131 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090804 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20090117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090202 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090117 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20080129 Year of fee payment: 13 |
|
PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: IT Effective date: 20091201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090731 |
|
PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: IT Effective date: 20091201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090117 |